CONMED Corporation (CNMD) Insider Trading Activity

NYSE$53.07+5.84 (12.37%)
Market Cap
$1.41B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
486 of 849
Rank in Industry
63 of 107

CNMD Insider Trading Activity

CNMD Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$161,091
2
100

Related Transactions

Glaze RichardChief Information Officer
0
$0
1
$10,591
$-10,591
Garner Todd WExecutive Vice President & CFO
0
$0
1
$150,500
$-150,500

About CONMED Corporation

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue …

Insider Activity of CONMED Corporation

Over the last 12 months, insiders at CONMED Corporation have bought $0 and sold $161,091 worth of CONMED Corporation stock.

On average, over the past 5 years, insiders at CONMED Corporation have bought $544,054 and sold $5.87M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,350 shares for transaction amount of $97,322 was made by BRONSON DAVID M (director) on 2024‑05‑13.

List of Insider Buy and Sell Transactions, CONMED Corporation

2025-11-21SaleGlaze RichardChief Information Officer
257
0.0008%
$41.21
$10,591
-2.95%
2025-11-06SaleGarner Todd WExecutive Vice President & CFO
3,500
0.011%
$43.00
$150,500
-5.90%
2025-09-12SaleFarkas Charlesdirector
2,000
0.0065%
$53.52
$107,049
-21.02%
2025-08-07SaleGarner Todd WExecutive Vice President & CFO
598
0.0019%
$52.45
$31,365
-21.72%
2025-05-05SaleFarkas Charlesdirector
4,000
0.0129%
$56.94
$227,768
-20.18%
2025-02-11SaleGlaze RichardChief Information Officer
257
0.0008%
$65.35
$16,796
-21.08%
2024-06-14SalePeters Stanley W IIIPresident AS and AET
4,000
0.0125%
$71.82
$287,280
-5.46%
2024-05-13PurchaseBRONSON DAVID Mdirector
1,350
0.0043%
$72.09
$97,322
-5.75%
2024-05-08PurchaseSchwarzentraub Barbara Jdirector
1,442
0.0047%
$69.26
$99,873
-0.68%
2024-05-06PurchaseAronson Martha Goldbergdirector
2,000
0.0065%
$70.98
$141,960
-2.40%
2024-04-30PurchaseBeyer PatChief Operating Officer
3,000
0.0098%
$68.30
$204,900
+1.76%
2023-12-04SalePeters Stanley W IIIPresident AS and AET
2,300
0.0074%
$109.93
$252,833
-32.96%
2023-11-07SalePeters Stanley W IIIPresident AS and AET
1,200
0.004%
$102.39
$122,874
-24.87%
2023-09-13SalePeters Stanley W IIIPresident AS and AET
2,000
0.0065%
$107.31
$214,629
-25.29%
2023-08-16SaleGarner Todd WExecutive Vice President & CFO
1,355
0.0045%
$112.00
$151,760
-23.56%
2023-06-15SaleHartman Curt RPresident, CEO and Chair
1,000
0.0033%
$136.00
$136,000
-26.80%
2023-06-08SaleFerrell John D.Executive Vice President - HR
1,700
0.0056%
$131.81
$224,077
-23.40%
2023-06-08SalePeters Stanley W IIIVP GM Advanced Surgery
5,000
0.0163%
$131.14
$655,676
-23.40%
2023-06-07SaleCONCANNON BRIANdirector
812
0.0027%
$129.01
$104,756
-21.13%
2023-05-22SalePeters Stanley W IIIVP GM Advanced Surgery
1,500
0.0049%
$120.89
$181,343
-13.18%
Total: 442
*Gray background shows transactions not older than one year

Insider Historical Profitability

6.99%
SHALLISH ROBERT D JREVP, Finance, CFO
53915
0.1809%
$2.55M212
+8.8%
Cohen Heather LEVP CORP HR
24456
0.0821%
$1.16M317
+31.38%
BRONSON DAVID Mdirector
16460
0.0552%
$777,405.8020
<0.0001%
Workman John Ldirector
16035
0.0538%
$757,333.0530
<0.0001%
Farkas Charlesdirector
14859
0.0499%
$701,790.57122
+4.46%
Jonas Daniel SSpecial Counsel & Corp Secy
13462
0.0452%
$635,810.26140
<0.0001%
Beyer PatChief Operating Officer
10807
0.0363%
$510,414.6122
<0.0001%
TRYNISKI MARK Edirector
8296
0.0278%
$391,820.0823
+40.92%
Kuyper Dirkdirector
5000
0.0168%
$236,150.0015
+37.51%
Hartman Curt RPresident, CEO and Chair
4299
0.0144%
$203,041.77410
+10.14%
Aronson Martha Goldbergdirector
2000
0.0067%
$94,460.0010
<0.0001%
Schwarzentraub Barbara Jdirector
1442
0.0048%
$68,105.6611
<0.0001%
*Gray background shows insiders who have made transactions during last year

CNMD Institutional Investors: Active Positions

Increased Positions146+44.65%5M+14.3%
Decreased Positions150-45.87%5M-15.66%
New Positions44New1MNew
Sold Out Positions55Sold Out2MSold Out
Total Postitions323-1.22%34M-1.36%

CNMD Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$188,189.0014.98%4.64M-187,551-3.88%2025-09-30
Vanguard Group Inc$146,314.0011.65%3.61M+62,917+1.77%2025-09-30
Earnest Partners Llc$113,403.009.03%2.8M-31,212-1.1%2025-09-30
Fuller & Thaler Asset Management, Inc.$70,295.005.6%1.73M-5,802-0.33%2025-09-30
Westwood Holdings Group Inc$53,883.004.29%1.33M+92,536+7.48%2025-09-30
Bank Of America Corp /De/$52,736.004.2%1.3M-207,705-13.76%2025-09-30
Dimensional Fund Advisors Lp$52,545.004.18%1.3M+214,126+19.78%2025-09-30
State Street Corp$51,162.004.07%1.26M-30,080-2.33%2025-09-30
Silvercrest Asset Management Group Llc$43,508.003.46%1.07M+221,799+26.03%2025-09-30
Capital Research Global Investors$41,846.003.33%1.03M-643,431-38.39%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.